Send to

Choose Destination
Headache. 1992 Oct;32(9):461-2.

Flunarizine in migraine: a double-blind placebo-controlled study (in a Saudi population).

Author information

Department of Clinical Neurosciences, Riyadh Armed Forces Hospital, Kingdom of Saudi Arabia.


We evaluated the effect of flunarizine (Fz) (10 mg/d) on migraine in a double-blind placebo-controlled design. The attacks' frequency, duration, severity and associated symptoms were compared before and after treatment. Forty-two patients completed a three-month trial period; 21 patients received Fz and 21 placebo. Statistical analysis showed no significant difference between Fz and placebo (p > 0.05). In this study Fz was not more efficient than placebo in migraine.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center